Risk-adjusted cancer-incidence rates (United States)

Cancer Causes and Control

Volumn 7, Issue 5, 1996, Pages 544-552

  Merrill, Ray M ^a   Feuer, Eric J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hysterectomy; Incidence; Lifetime risk; Prevalence; United States; Uterine cancers

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; FEMALE; HUMAN; HYSTERECTOMY; MALE; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; UTERINE CERVIX CANCER;

EID: 0029793847     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00051888     Document Type: Article

References (32)

1. Selvin S. Statistical Analysis of Epidemiologic Data. New York, NY (USA): Oxford University Press,1991.
2. Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK, eds. Cancer Statistics Review 1973-1991. Roskville, MD (USA): National Cancer Institute, 1994; NIH Pub. No. 94-2789.
3. Verhagen AF, Travilla G, van de Wal HJ, Cox AL, Lacquet LK. Multiple primary lung cancers. Thorac Cardiovasc Surg 1994; 42: 40-4.
4. Antakli T, Schaefer RF, Rutherford JE, Read RC. Second primary lung cancer. Ann Thorac Surg 1995; 59: 863-6.
5. Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus, and lung. Int J Radiât Oncol Biol Phys 1989; 17: 467-76.
6. Prior P, Waterhouse JAH. Multiple primary cancers of the breast and ovary. Br J Cancer 1981; 44: 628-36.
7. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: A population-based study in Sweden. Br J Cancer 1996; 73: 255-9.
8. Day NE. Cumulative rate and cumulative risk. In Muir C, Waterhouse J, Mack T, Whelan S, eds. Cancer Incidence in Five Continents, Volume V. Lyon, France: International Agency for Research on Cancer, 1987; IARC Sci. Pub. No. 88: 862-4.
9. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume 1: The Analysis of Case-control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.
10. Lyon JL, Gardner JW. The rising frequency of hysterectomy: its effect on uterine cancer rates. Am J Epidemiol 1977; 105: 439-43.
11. Feuer EJ, Wun L, Boring CC. Probability of developing cancer. In: Miller BA, Ries LAG, Hankey BR, et al, eds. Cancer Statistics Review: 1973-1989. Rockville, MD: National Cancer Institute, 1992; NIH Pub. No. 92-2789: 1-8.
12. Feuer EJ, Wun L, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer. JNCI 1993; 85: 892-7.
13. Adami HO, Gunnarsson T, Sparen P, Eklund G. The preva-lence of cancer in Sweden 1984. Acta Oncologia 1989; 28: 463-70,
14. Feldman AR, Kessler L, Myers MH, Naughton, MD. The prevalence of cancer: estimates based on the Connecticut Tumor Registry. New Eng J Med 1986; 315: 1394-7.
15. Capocaccia R, Verdecchia A, Micheli A, Sant M, Gatta G, Berrino F. Breast cancer incidence and prevalence estimated from survival and mortality. Cancer Causes Control 1990; 1: 23-9.
16. US Bureau of the Census, Census of population 1970. In: Muir C, Waterhouse J, Mack T, Whelan S, eds. Cancer Incidence in five Continents, Volume V. Lyon, France: International Agency for Research on Cancer, 1987; IARC Sci. Pub. No. 88: 792.
17. Connelly RR, Campbell PC, Eisenberg H. Central registry of cancer cases in Connecticut. Public Health Rep 1968; 83: 386-90.
18. Gershman ST, Flannery JT, Barrett H, Nadel RK, Meigs JW. Development of the Connecticut Tumor Registry. Conn Med 1976; 40: 697-701.
19. MacMahon B, Worcester J. Age at Menopause. Washington, DC: US Public Health Service, 1966; USPHS Pub.No. 1000, Series 11, No. 19.
20. Graves EJ. National hospital discharge survey: annual summary, 1990, Hyattsville, MD (USA): National Center for Health Statistics, 1992; DHHS Pub. No. (PHS) 92-1773, (Vital and Health Statistics, Series 13, No. 112).
21. International Classification of Diseases, 9th Revision, Clinical Modification, 3rd Ed. Washington, DC: Public Health Service, 1989; DHHS Pub. No. (PHS) 89-1260.
22. Pokras R, Hufnagel VG, NCHS. Hysterectomies in the United States, 1965-84. Hyattsville, MD (USA): US Department of Health and Human Services, Public Health Service, CDC, 1987; DHHS Pub. No. (PHS)87-1753, (Vital and Health Statistics; Series 13, No. 92)
23. Goldberg ID, Levin ML, Gerhardt PR, Handy VH, Cashman RE. The probability of developing cancer. JNCI 1956; 17: 155-73.
24. Zdeb MS. The probability of developing cancer. Am J Epidemiol 1977; 106: 6-16.
25. Siedman H, Silverberg E, Bodden A. Probabilities of eventually developing and dying of cancer (risk among persons previously undiagnosed with cancer). CA-Cancer J Clin 1978; 28: 33-46.
26. Pokras R. Hysterectomy, past, present, and future. Stat Bull Metrop Insur Co 1989; 70: 12-21.
27. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-90. Obstet Gynecol 1994; 83: 549-55.
28. Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the Surveillance, Epidemiology, and End Results program data: recent trends in cancer mortality rates. JNCI 1992; 84: 872-7.
29. Morris CR, Perkins CI, Wright WE, Snipes KP, Young JL. Impact of inclusion of subsequent primary cancers on estimates of lifetime risk of developing cancer. JNCI 1996; 88: 456-8.
30. Benichou J, Gail MH, Mulvihill JJ, Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14: 103-10.
31. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CACancer J Clin 1995; 45: 8-30.
32. Giles K, Flynn PJ, Dalton R, Zera R. National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial. Minn Med 1993; 76: 25-7.